focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thankyou brazos.
For this information mine held with broker , no information.
RE: Arcturis Data limited6 Apr 2024 19:36
100:1 consolidation. So they are proposing a consolidation and a sub-division. I received a copy of the document and you are spot on micru. I quote ''The purpose of the sub-division is to reduce the nominal value of the Consolidated Ordinary shares to a level which provides flexibility for future issues of ordinary shares''
I hope we will be invited to participate should there be any future issuing of equity, otherwise we will be diluted to oblivion. Those who own less that 100 shares will cease to be shareholders following this proposed exercise.
In any case, I hope LTHs will be able to come out with something in the end.
Stock Split Adjustment on account today.
Costly gamble .
Looks like it will be complete loss eventually no listing , old share holders interest will not be looked after .
Might of been a little mad .
Looks like others posted buys at same time.
>Not sure what made me top up on 25th May 2022
Eternal optimism, haha! The optimism is still valid.
Not sure what made me top up on 25th May 2022
Tue, 19th Apr 2022 (Alliance News)
Sensyne Health shares plummet as AIM delisting proposed
Sensyne Health PLC shares slump on Tuesday as the company proposed delisting from London's AIM junior market.
The company is seeking approval from its shareholders for the delisting of the shares, in accordance with AIM rules, Sensyne Health explained.
It will hold a general meeting on May 20.
Sensyne Health shares were 32% lower at 1.24 pence each in London on Tuesday morning.
The firm, led by Alex Snow as its new chief executive officer since Monday, amended and restated a note purchase agreement to provide for the issue of up to GBP20 million of loan notes. This brings the total number of loan notes to GBP26.4 million.
The company said the loan notes are purchased - or will be purchased - in tranches.
One tranche of a principal amount of GBP6.4 million was issued to original purchasers on January 28.
Another tranche of GBP6.0 million will be issued to Gatemore Investment Partners I LP, Lansdowne and MNL (Hambro Perks) Nominees Limited on or around April 21.
Two subsequent tranches of loan notes will be issued at the request of the company, with new Sensyne Health Chief Executive Alex Snow, who is the former CEO of Lansdowne Partners UK LLP, allowed to subscribe for up to GBP2.0 million of additional notes.
The company had been under a formal sales process since November.
"In light of the amended financing terms, the board has decided to end the formal sale process with immediate effect," Sensyne said.
The Oxford, England-based clinical artificial intelligence company is also seeking the approval of shareholders to re-designate ordinary shares of 10 pence. Under the plan, those shares will be sub-divided and re-designated into one ordinary share of GBP0.008 in the capital of the company and GBP0.092 as a deferred share in the capital of the company.
Isn't the news going to be it will delist? Is there a realistic chance that this will not happen?
Not a great volume at the moment . Need some news to get things ignited. Bought a few more the drop.
The spread is over 14% today I see ??
Topped up at 1.2p lifted midday .
Not sure why I got involved here now , but on a role and Margrets blessings last few days seem to be working .
Can it ever bounce Currently no break
This is defo being watched carefully..people buying and taking the risk...98% down....potential multi bagger...just imagine in a couple years its back to £1 level
This is as low as it can possibly get, with new CEO with Hugh reputation in, funding secured and AIM listing subject to vote..all for 1.25p!
I’m jealous, best I got today was 1.32.
1.25p went through 10.45am